NEXTCURE, INC Current Assets
NEXTCURE, INC (NXTC) had Current Assets of $22.25 million as of 2026-06-30, per its S-4 filed 2026-08-18.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-18
- 2026-06-30: Assets, Current $22.25M.
- 2026-03-31: Assets, Current $31.74M.
- 2025-12-31: Assets, Current $43.75M.
- 2025-09-30: Assets, Current $32.64M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $22.25M S-4 · filed 2026-08-18 |
| 2026-03-31 | $31.74M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $43.75M S-4 · filed 2026-08-18 |
| 2025-09-30 | $32.64M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $40.02M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $58.90M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $71.81M S-4 · filed 2026-08-18 |
| 2024-09-30 | $78.69M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $90.45M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $102.55M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $112.72M 10-K · filed 2025-03-06 |
| 2023-09-30 | $122.68M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $135.30M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $148.92M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $163.98M 10-K · filed 2024-03-21 |
| 2022-09-30 | $175.31M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $192.95M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $208.93M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $227.82M 10-K · filed 2023-03-02 |
| 2021-09-30 | $243.04M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $258.63M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $273.05M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $287.98M 10-K · filed 2022-03-03 |
| 2020-09-30 | $296.98M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $315.07M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $326.66M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $340.00M 10-K · filed 2021-03-04 |
| 2019-09-30 | $189.15M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $196.52M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $131.64M 10-Q · filed 2019-06-10 |
| 2018-12-31 | $135.78M 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |